Добірка наукової літератури з теми "Aluminum hydroxide adjuvant (Alum)"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Aluminum hydroxide adjuvant (Alum)".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Aluminum hydroxide adjuvant (Alum)"
Hem, Stanley L., Cliff T. Johnston, and Harm HogenEsch. "Imject® Alum is not aluminum hydroxide adjuvant or aluminum phosphate adjuvant." Vaccine 25, no. 27 (June 2007): 4985–86. http://dx.doi.org/10.1016/j.vaccine.2007.04.078.
Повний текст джерелаDavison, Clara J., Haley A. Partlow, Stephanie K. Lathrop, Karthik Siram, Walid Abdelwahab, David J. Burkhart, and Jay Evans. "Combinations of alum and synthetic toll-like receptor agonists as adjuvants for CoVID-19 vaccines." Journal of Immunology 206, no. 1_Supplement (May 1, 2021): 30.07. http://dx.doi.org/10.4049/jimmunol.206.supp.30.07.
Повний текст джерелаNear, Karen A., Anthony W. Stowers, Dragana Jankovic, and David C. Kaslow. "Improved Immunogenicity and Efficacy of the Recombinant 19-Kilodalton Merozoite Surface Protein 1 by the Addition of Oligodeoxynucleotide and Aluminum Hydroxide Gel in a Murine Malaria Vaccine Model." Infection and Immunity 70, no. 2 (February 2002): 692–701. http://dx.doi.org/10.1128/iai.70.2.692-701.2002.
Повний текст джерелаKaracs, Jasmine, Manuel Reithofer, Claudia Kitzmüller, Markus Kraller, Stefanie Schmalz, Sonja Bleichert, Johannes B. Huppa, Hannes Stockinger, Barbara Bohle, and Beatrice Jahn-Schmid. "Adjuvants and Vaccines Used in Allergen-Specific Immunotherapy Induce Neutrophil Extracellular Traps." Vaccines 9, no. 4 (April 1, 2021): 321. http://dx.doi.org/10.3390/vaccines9040321.
Повний текст джерелаPrior, J. Timothy, Christopher Davitt, Jonathan Kurtz, Patrick Gellings, James B. McLachlan, and Lisa A. Morici. "Bacterial-Derived Outer Membrane Vesicles are Potent Adjuvants that Drive Humoral and Cellular Immune Responses." Pharmaceutics 13, no. 2 (January 20, 2021): 131. http://dx.doi.org/10.3390/pharmaceutics13020131.
Повний текст джерелаKool, Mirjam, Thomas Soullié, Menno van Nimwegen, Monique A. M. Willart, Femke Muskens, Steffen Jung, Henk C. Hoogsteden, Hamida Hammad, and Bart N. Lambrecht. "Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells." Journal of Experimental Medicine 205, no. 4 (March 24, 2008): 869–82. http://dx.doi.org/10.1084/jem.20071087.
Повний текст джерелаZhang, Zhe, Xin-Pu Li, Feng Yang, Jin-Yin Luo, Xu-Rong Wang, Long-hai Liu, and Hong-Sheng Li. "Immune Responses in Mice Immunized with Mastitis Multiple Vaccines Using Different Adjuvants." Acta Scientiae Veterinariae 46, no. 1 (August 10, 2018): 8. http://dx.doi.org/10.22456/1679-9216.84088.
Повний текст джерелаChen, Qiuting, Nan Wu, Yuhui Gao, Xiaojun Wang, Jie Wu, and Guanghui Ma. "Alum Pickering Emulsion as Effective Adjuvant to Improve Malaria Vaccine Efficacy." Vaccines 9, no. 11 (October 26, 2021): 1244. http://dx.doi.org/10.3390/vaccines9111244.
Повний текст джерелаHawksworth, David, and Joan Tyner. "Evaluation of Adjuvant Regimens for Antibody Development in Rabbits (36.29)." Journal of Immunology 178, no. 1_Supplement (April 1, 2007): S17—S18. http://dx.doi.org/10.4049/jimmunol.178.supp.36.29.
Повний текст джерелаSasaki, Eita, Hideki Asanuma, Haruka Momose, Keiko Furuhata, Takuo Mizukami, and Isao Hamaguchi. "Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses." PLOS Pathogens 17, no. 8 (August 30, 2021): e1009890. http://dx.doi.org/10.1371/journal.ppat.1009890.
Повний текст джерелаДисертації з теми "Aluminum hydroxide adjuvant (Alum)"
Bortolatto, Juliana. "Toll-like receptor 4 (TLR4) na modulação da imunidade do tipo 2." Universidade de São Paulo, 2008. http://www.teses.usp.br/teses/disponiveis/42/42133/tde-18112008-172851/.
Повний текст джерелаEpidemiological and experimental data suggest that bacterial lipopolysaccharides (LPS) can either protect from or exacerbate allergic asthma. LPS triggers immune responses through Toll-like receptor (TLR) 4 that in turn activates two major signaling pathways via either MyD88 or TRIF adaptor proteins. LPS is a pro-Th1 adjuvant while aluminum hydroxide (Alum) is a strong Th2 adjuvant, but the effect of mixing both adjuvants on development of lung allergy has not been investigated. We determined whether natural (LPS) or synthetic (ER-803022) TLR4 agonists adsorbed onto alum adjuvant affect allergen sensitization and development of airway allergic disease. To dissect LPS-induced molecular pathways we used TLR4, MyD88, TRIF, or IL-12/IFN-g deficient mice. Mice were sensitized subcutaneously to allergens such as ovalbumin (OVA) or tetanus toxoid (TT) with or without TLR4 agonists coadsorbed onto Alum and challenged twice via intranasal route with the same allergens. The development of type 2 immunity was evaluated 24 h after last allergen challenge. We found that sensitization with OVA or TT plus LPS co-adsorbed onto Alum impaired allergeninduced Th2-mediated responses such as airway eosinophilia, type 2 cytokines secretion, airway hyperreactivity, mucus hyper production and serum levels of IgE or IgG1 anaphylactic antibodies. Although the levels of IgG2a, a Th1 affiliated isotype increased, investigation into the lung-specific effects revealed that LPS did not induce a Th1 pattern of inflammation. LPS impaired the development of Th2 immunity, signaling via TLR4 and MyD88 molecules via the IL-12/IFN-g axis, but not through TRIF pathway. Moreover, the synthetic TLR4 agonists that proved to have a less systemic inflammatory response than LPS also protected against allergic asthma development. TLR4 agonists co-adsorbed with allergen onto Alum down modulate Th2 immunity and prevent the development of polarized T cell-mediated airway inflammation. Thus, our work clarifies the effect of TLR4 signaling in allergic sensitization and indicates that TLR4 agonists with low toxicity might be useful for down regulating the pro-Th2 adjuvant activity of alum and consequently decrease the induction of allergy.
Li, Xinran. "Vaccine formulation development : towards addressing major limitations of vaccines that are adjuvanted with aluminum salts." Thesis, 2013. http://hdl.handle.net/2152/28737.
Повний текст джерелаtext
Книги з теми "Aluminum hydroxide adjuvant (Alum)"
Centre, Alberta Environmental. Binding, uptake and toxicity of alum sludge. [Vegreville, Alta.]: The Centre, 1987.
Знайти повний текст джерелаЧастини книг з теми "Aluminum hydroxide adjuvant (Alum)"
Setyawati, Damai Ria, Sjaikhurrizal El Muttaqien, Donny Ramadhan, and Etik Mardliyati. "Effect of Sterilization on Protein Adsorption of Micro- and Nano-sized Aluminum Hydroxide Adjuvant." In Proceedings of the 1st International Conference for Health Research – BRIN (ICHR 2022), 824–32. Dordrecht: Atlantis Press International BV, 2023. http://dx.doi.org/10.2991/978-94-6463-112-8_75.
Повний текст джерела